A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”
Two compelling new studies are building on a hypothesis suggesting age-related dementia is caused by a leaky blood-brain barrier, triggering neuro-inflammation and, ultimately, brain cell damage. The research reveals a novel anti-inflammatory drug can reverse brain aging in senile mice, but experts suggest the studies are interesting but not particularly applicable to human cases of dementia.
New research from Columbia University, presented at the American Heart Association’s Hypertension 2019 Scientific Sessions, is adding weight to a growing body of evidence connecting high blood pressure to the onset of cognitive decline and dementia. The study suggests treating high blood pressure can potentially slow the rate of cognitive decline.
The numerous folds which cover our brains change over time, becoming slacker as we age, according to a study.
What’s more, this slacking was seen to be more pronounced in those with Alzheimer’s disease.
Researchers believe that learning more about how the mechanisms which control how folding changes with age could potentially be used to help diagnose brain diseases and spot dementia.
Scroll down for video